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ABSTRACT 
Hypercholesterolemia or hyperlipidemia has been established as an important risk factor of 
cardiovascular disease. Patients with hypercholesterolemia usually require a prolonged 
treatment; and the newer and more potent generation of antilipid agents are costly.   
In Bali there are several types of seaweed that are generally consumed by the local 
people and known by the local names of Bulung Boni (Caulerpa spp.) and Bulung Sangu 
(Gracilaria spp.). Preliminary studies on the effect of Bulung Boni and Bulung Sangu extracts 
appeared to improve lipid profile, but the available data are still very limited both in extent 
and depth, and further investigations were considered relevant and needed. 
          This experimental study used completely blind randomized design, using a total of 24 
Wistar rats divided into six sample groups of equal size, all fed with a diet high in cholesterol 
content. The six sample groups were respectively designated as negative control group, 
positive control group, and four treated sample groups, respectively fed orally with a dose of 
20 mg and 60 mg extracts of Bulung Boni per 100g of body weight per day,  and 20 mg and 
60 mg extracts of Bulung Sangu per 100g body weight per day. Each treatment was repeated 
four times.  
Our study showed that rats fed with high-cholesterol diet and treated with oral Bulung 
Boni or Bulung Sangu extract at a dose of 20 mg and 60 mg/100 g bw/ day were associated 
with statistically significantly increased plasma HDL levels (p < 0.05), and statistically 
significant decreased plasma LDL and total cholesterol levels (p < 0.05) as compared with 
those of rats fed with high cholesterol diet without treatment with Bulung Boni or Bulung 
Sangu extracts. 
From our data it could be implied that Bulung Boni and Bulung Sangu extracts 
improve lipid profile in the Wiatar rat by significantly increasing plasma HDL level, and 
lowering LDL and total cholesterol levels. 
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INTRODUCTION 
In some countries such as Japan, Korea, China, Vietnam, Indonesia, Peru, 
Scandinavia, Scotland, and  Philippines, seaweed has been used as a source of food, medicine, 
and  raw material for various types of industries. Seaweed has  potential nutrient content such 
as carotenoids, vitamins, fatty acids, carbohydrates, minerals, and other essential substances. 
Carotenoids have important biological functions as an antioxidant, and immunostimulatory 
which can prevent the disease, anti-inflammatory, anti-stress, anti-aging, and protect the skin 
from the harmful effects of ultraviolet radiation 1,2. Carotenoids are antioxidant that are 
potential in protecting against membrane lipid peroxidation 3. Carotenoids are derived from  
natural sources more safe  than synthetic carotenoids 4. 
             Antioxidants can protect the body from free radicals attack and reduce its negative 
impact. Free radicals are  necessary for the survival of several physiological processes in the 
body, especially for electrons transport, but the excessive free radical can harm the body 
because it can damage macromolecules such as protein in cells, and DNA (deoxyribo nucleic 
acid). Macromolecular damage can improve cell death 5. 
 In addition besides  effects of oxidants, cholesterol also affects the development of 
degenerative diseases. The development of  people live style that  consume more fatty foods, 
especially of saturated fatty acid intake tend to  cholesterol to be higher than the level of need. 
Intake of foods with high cholesterol content can increase cholesterol levels in the blood. This 
condition called hypercholesterolemia. One of the major atherosclerosis risk factors are 
dyslipidemia, and the prevalence of dyslipidemia in Indonesia has increased 6.  
Anticipating the effect of  hypercholesterolemia in cardiovascular disease, has 
developed several hypolipidemic drugs such as niacin, gemfibrozil, and the class of statins.  
The treatment of patients with hypercholesterolemia require a long period, and  high costs, the 
study should be developed to obtain  more effective drugs with a cheaper price, and less side 
effects. Natural ingredients from the sea, such as seaweeds need to be explored because of its 
carotenoids content that has function as an antioxidant and lowering blood cholesterol levels. 
In Bali there are several types of seaweed that has  long  been used as a source of food 
by people.  Types of seaweeds local name are  Bulung Boni (Caulerpa spp.) and Bulung 
Sangu (Gracilaria spp). However studies on the effect of Bulung Boni and Bulung Sangu to 
improve lipid profile are very limited, therefore it is still very relevant for further study.The 
results of study can provide information to the public about Bulung Boni and Bulung Sangu 
benefits in improving of lipid profile in cases of dyslipidemia.  
 
MATERIAL AND METHODS 
Material in this study consist of Bulung Boni (Caulerpa spp.), Bulung Sangu     
(Gracilaria spp.).  White rats used were male rats, wistar strain,  2.5  up to 3 month of age, 
200 g to 225 g of weight, profile thio Uracil (PTU),   standard diet,  foods high in cholesterol 
is made in the Laboratory of Pharmacology Faculty of Medicine Udayana University with a 
mixture of 1% dried pig brain, 5% egg yolk cooked, 10% lard, 1% coconut oil, and 83% 
standard diet with drinking water containing 0.01% PTU 7,  and cholesterol kit. 
This experimental study used completely blind randomized design, using a total of 24 
Wistar rats divided into six sample groups of equal size, all fed with a diet high in cholesterol 
content. The six sample groups were respectively designated as negative control group            
(KN), positive control group (KP), and four treated sample groups, respectively fed orally 
with a dose of 20 mg and 60 mg extracts of Bulung Boni per 100g of body weight per day 
(BB20 and BB60),  and 20 mg and 60 mg extracts of Bulung Sangu per 100g body weight per 
day (BS20 and BS60). Each treatment was repeated four times.  
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Preparation of seaweed extracts  
Dried seaweed were grinded  until smooth and become powder.  Seaweed powder is 
mixtured with 96% ethanol solution with a ratio of 3:1, then stirred with a magnetic stirrer for 
one hour at room temperature. Furthermore, filtered with Whatman paper No. 42 in order to 
obtain a filtrate, then concentrated by rotary evaporator.  
 
Seaweed extracts treated  in rats  
In one cage was placed as many as four rats that had previously adapted for one week 
in the laboratory. Standard diet, cholesterol diet, and beverages rats administered daily ad 
libitum. Seaweed extract was administered orally by zonde with dose 20 mg  and 60 mg/100 g  
body weight rat/day according to treatment.  
 
Blood sample  
  After 30 days treatment,  rats was fasted for 18 hours. Bloods sample was taken 
through the sinus orbitalis as much as 2 cc. Measurement of cholesterol levels using 
enzymatic CHOD PAP Test colorimeter method. Blood samples of rats as much as 1 cc put 
into test tube, and   plasma from blood was separated with centrifuge for 20 minutes at 1500 
rpm.  10 µl of plasma was mixed with 1000 µl of reagent. Sample tubes incubated for 10 
minutes at temperature of  20-250C.   Samples inserted into the spectrophotometer with a 
wavelength of 500 nm 9.  
 
Data Analysis  
Analysis of HDL, LDL,and  total cholesterol performed with test of homogeneity of 
variance using Levene's Test at 5% significance level. If the variance is not homogeneous, the 
data must be  transformation. To determine the effect of treatment, the data were analyzed 
with analysis of variance at 5% significance level. If the F test showed a significant difference 
, the treatment was tested furthermore by BNJ at 5% significance level.  
 
RESULTS 
Levels of high density lipoprotein (HDL) 
Levene's test  showed that the treatment with Bulung Boni and Bulung Sangu extracts 
on observations of HDL cholesterol, LDL, and  total cholesterol, have a homogeneous 
variance   (p> 0.05) (Table 1). 
Table 1. Levene’s  Test for  Homogeneity of Variances 
Variable MS effect MS error F P 
HDL     2,0870   1,0409 2,0049 0,1266 
LDL 149,0894 77,1862 1,9315 0,1387 
Total Cholesterol 118,7493 63,5314 1,8691 0,1500 
The highest plasma HDL level found in negative control  78.25 ± 1.72 mg / dl, then 
BB60 62.34 ± 1.19 mg / dl, BS60 61.53 ± 3.84 mg / dl, 58.44 ± BS20 1.19 mg / dl, BB20 
55.68 ± 1.44 mg / dl, and the lowest in the positive control with plasma HDL level 45.29 ± 
1.11 mg / dl (Figure 1). 
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Figure 1. .Plasma HDL Level  Wistar Rat   in Negative Control (KN), 
         Positive Control (KP), BB20, BB60, BS20, and  BS60 
 
Analysis of variance of plasma HDL level Wistar rats treated high-cholesterol diet 
with Bulung Boni and Bulung Sangu extracts showed significant differences (p <0.05) in 
various treatments. To determine the effect of each treatment on plasma HDL performed  with 
multiple comparation test. Plasma HDL level in positive control (KP) was significantly lower 
compared with KN, BB20, BS20, BB60, and BS60. Plasma HDL level in BB20 was 
significantly higher compared with positive controls, but did not differ significantly with 
BS20. Plasma HDL level in BB60 was significantly higher compared with the KP, BB20, and 
BS20, but non significantly different with BS60. Plasma HDL level in KN was significantly 
higher compared with  KP, BS20, BB20, BS60, and BB60. 
 
 Levels of  low density lipoprotein (LDL) 
The lowest plasma LDL  level  showed in negative control was 21.26 ± 3.29 mg/dl, 
then BB60 48.00 ± 10.97 mg/dl, BS60 53.86 ± 20.89 mg/dl, 113.18 ± BB20 18.91 mg/dl, 
BS20 117.33 ± 26.41 mg/dl, and positive controls with the highest average level  of plasma 
LDL 233.38 ± 19.86 mg/dl (Figure 2) 
 
 
 
Figure 2.    Plasma LDL Level Wistar Rat  in Negative Control  (KN),   
            Positive Control (KP), BB20, BB60, BS20, and  BS60 
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Analysis of variance of plasma LDL level Wistar rats treated  high-cholesterol diet 
with  Bulung Boni and Bulung Sangu extract showed significant (p <0.05) in various 
treatments. To determine the effect of each treatment on plasma LDL level performed with 
multiple comparation test. Plasma LDL level in KP was significantly higher compared with 
KN, BB60, BS60, BB20, and BS20. Plasma LDL level  in BB20, significantly higher 
compared  with BB60, BS60, and KN, but did not differ significantly with BS20. Plasma 
LDL level  in BB60 significantly lower compared with the KP, BS20, BB20 but non 
significantly different with BS60.  Plasma LDL level in  negative control were significantly 
lower compared with BB60, BS60, BB20, BS20, and KP. 
 
 Levels of total cholesterol 
The highest plasma total cholesterol level found in positive control  311.80 ±        
18.47 mg/dl, then BS20 196.07 ± 25.86 mg/dl, BB20 17.42 ± 190.07 mg/dl, BS60 132.96 ± 
18.11 mg/dl, BB60 128 ± 10.79 mg/dl, and the lowest in the negative control with total 
cholesterol 114.98 ± 4.59 mg/dl (Figure 3). 
 
 
Figure 3.  Plasma Total Cholesterol Level  Wistar Rat  in  Negative Control (KN), 
  Positive Control (KP), BB20,  BB60, BS20, and BS60. 
 
Analysis of variance of total cholesterol Wistar rats treated  high-cholesterol diet with  
Bulung Boni and Bulung Sangu extract showed significant (p <0.05) in various treatments.  
To determine the effect of each treatment on plasma total cholesterol level performed with 
multiple comparation test. Plasma total cholesterol level in positive control (KP) was 
significantly higher compared with negative control (KN), BB20, BS20, BB60, and BS60. 
Total cholesterol level in BS20 were significantly higher compared with KN, BB60, BS60, 
but non significantly different with BB20. Total cholesterol level in BB60 significantly lower 
compared with positive control (KP), BS20, and BB20, but non significantly different with 
BS60, and KN. 
 
DISCUSSIONS 
Levels of high density lipoprotein (HDL)  
High-cholesterol diet with Bulung Boni and Bulung Sangu  extracts dose of  20 mg/ 
100 g bw rat/day resulted in plasma HDL level were significantly higher than treated only 
high-cholesterol diet (positive control). Bulung Boni and Bulung Sangu extracts with a higher 
dose is 60 mg/100 g rat bw/day can increase plasma HDL level that were significantly higher 
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compared with dose of 20 mg/100 g bw rat/day. Bulung Boni and Bulung Sangu extracts dose 
of  60 mg/100 g bw rat/day can increase plasma HDL level above 60 mg/dl, approximately  
62.34 ± 1.19 mg/dl in BB60, whereas in BS60 61.53 ± 3.84 mg /dl. This plasma HDL level 
were high.  Plasma HDL level of  less than 40 mg /dl are low, whereas above  60 mg/dl is 
high10. HDL cholesterol level above 60 mg/dl can be considered as a protective effect against 
heart disease 11.  
Bulung Boni extract can  increase plasma HDL level  in rats, therefore significantly 
higher than fed  only high  cholesterol diet, but did not differ significantly with Bulung Sangu 
extract. This is due to in Bulung Sangu and Bulung Boni there are several types of the same 
carotenoid such as beta carotene, chlorophyll b, antheraxanthin, astaxanthin free, and 
neoxanthin, therfore the ability to increase plasma HDL level did not differ significantly. Any 
increase in plasma HDL cholesterol level at 1 mg/dl can reduce the risk of coronary heart 
disease in men by 2% and 3% in women 12. High level of HDL in the blood will accelerate the 
process of transporting cholesterol to the liver, therefore reducing the possibility of 
accumulation of cholesterol in the blood vessels 13. Dietary carotenoids may act as a 
hypocholesterolemic agent, and inhibiting the enzyme HMG-CoA reductase is an important 
role in cholesterol synthesis 14. 
 
Levels of low density lipoprotein (LDL)  
In rats fed high-cholesterol diet with Bulung Boni and Bulung Sangu extract with a 
dose of 20 mg/100 g bw  rat/day had plasma LDL level are significantly lower than without  
Bulung Boni or Bulung Sangu extract. In BS20 117, 33 ± 26.41 mg/dl, and  BB20 113.18 ± 
18.91 mg/dl. Bulung Boni and Bulung Sangu extract with higher dose, that was 60 mg/100 g 
bw rat /day can reduce plasma LDL level that were significantly lower compared with dose of 
extract 20 mg/ 100 g bw  rat /day. Plasma LDL level in BB60 48.00 ± 10.97 mg/dl, while in  
BS60 plasma LDL level higher at 53.86 ± 20.89 mg /dl, but did not differ significantly with 
BB60. This shows that Bulung Boni and Bulung Sangu extracts with a dose of  60 mg/100 g 
bw  rat /day can reduce plasma LDL level therefore achieve to optimal LDL level.  
LDL level less than 100 mg /dl is optimal LDL level, 100-129 mg/dl is near optimal 
level of LDL, 130-159 mg/dl is the highest normal range, 160-189 mg/dl is high LDL 
category, more than 190 mg/dl, very high category 10. 
 
Levels of total cholesterol  
In Wistar rats fed only high-cholesterol diet without Bulung Boni and Bulung Sangu 
extracts (positive control) resulted in total cholesterol level was significantly higher compared 
with the treatment BS20, BB20, BS60, BB60, and KN, approximately 311.80 ± 18.47 mg/dl, 
it is called hypercholesterolemia, because of total cholesterol levels in the blood  more than 
240 mg/dl.  
Increased cholesterol levels can be caused by  the diet contains too much cholesterol 
and fat, therefore the body is unable to control it, the excretion of cholesterol into the colon 
trough bile acid is very limited, and the production of cholesterol in the liver more than the 
body needed15.  
 High-cholesterol diet with Bulung Boni or Bulung Sangu extract with a dose of 60 
mg/100 g bw rat/day resulted in total cholesterol level  were significantly lower compared 
with dose of 20 mg/100 g bw rat/day, but did not differ significantly with negative control 
(KN). This shows that Bulung Boni and Bulung Sangu extracts with a dose of 60 mg/100 g bw 
rat /day can lower total cholesterol  level  near to total cholesterol in rats treated only  
standard diet (negative control).   Bulung Boni and Bulung Sangu extracts can lower 
cholesterol level below 200 mg /dl, this is due to carotenoid content in Bulung Boni and 
Bulung Sangu function as hypocholesterolemic. 
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Carotenoid has a very important biological functions as an antioxidant, immune 
system, prevent degenerative diseases, anti-inflammatory, anti-stress, inhibit lipid 
peroxidation, and lower blood cholesterol level 16 
 
CONCLUSSION 
Bulung Boni and Bulung Sangu extracts  improve lipid profile by increasing plasma 
HDL level, lowering LDL and total cholesterol levels Wistar rat fed high  cholesterol diet 
significantly. 
 
ACKNOWLEDGMENT 
We would like  thanks are due to Director of Postgraduate Program of Udayana 
University, DP2M Dikti for a Doctoral Dissertation Grant, Head and technician of 
Pharmacology Laboratory  Udayana University, and  PAU UGM laboratory, which has 
helped this research. Without their kind support, this study would not have been completed. 
 
REFERENCES 
1. Kato, M.,  Ikona, Y.,  Matsumoto, H., Sugiura, M., Hyodo, H., dan Yano, M. 2004. 
Accumulation of Carotenoids and Expression of Carotenoids Biosynthetic Genes  
During Maturation in Citrus Fruit. Plant Physiol February; 134 (2): 824-837. 
 
2. El-Baky,H.H., El-Baz, F.K., dan  El-Baroty,G.S. 2007. Production  of Carotenoids from  
Marine Microalgae and its Evaluation as Safe Food Colorant and Lowering 
Cholesterol Agents. American Eurasian J.Agric. Sci. 2(6): 792-800. 
 
3. Siems, W.G.,  Sommerburg,O.,  dan Frederick J.G.M. 2002. Hand book of Antioxidants.  
Second Edition. Revised and Expandeed Edited by Erique Cadences Lester Packer. 
University of Southern California School of Pharmacy. Los Angeles California. p 235-
245 
 
4. Alan, M. 2006.  Carotenoids and Other Pigments as Natural Colorants. Pure Appl.Chem,  
 Vol 78 (8): 1477-1491 
 
5. Haliwell, B. 2002. Food Derived Antioxidants: How to Evaluate Their Importance in Food  
and in Vivo. Hand book of Antioxidants. Second Edition. Revised and Expandeed 
Edited by Erique Cadences Lester Packer. University of Southern California School of 
Pharmacy. Los Angeles California. p 1-33. 
 
6. Anwar, T.B. 2004. Dislipidemia Sebagai Faktor Resiko Penyakit Jantung Koroner. e-USU  
 Repository 
 
7. Pengembangan dan Pemanfaatan Obat Bahan Alam. 1991. Pedoman Pengujian dan 
Pengembangan Fitofarmaka. Penapisan Farmakologi, Pengujian Fitokimia,  dan 
Pengujian Klinik. Kelompok Kerja Ilmiah. Jakarta: Yayasan Pengembangan Obat 
Bahan Alam Phyto Medica. 
 
8. Murdiyanto, B. 2008. Rancangan Percobaan. Available from  
 URL:http://www.ikanlaut.tripod.com. 7 Juli 2009. 
 
 
8 
 
9. Rahayu, T. 2005. Kadar Kolesterol Darah Tikus Putih ( Rattus norvegicus L) Setelah  
 Pemberian Cairan Kombucha Per-Oral. Jurnal Penelitian Sains & Teknologi, 6(2):  
85 – 100. 
 
10. Jae, K.W. 2008. Kolesterol. Yayasan Jantung Indonesia. Available from:  
 URL:http://www.heartinfo.org. 17 September 2008. 
 
11. Hangbao, M., Young, J., dan Shen, C. 2008. HMG-CoA Reductase (3 hydroxy-3 methyl  
glutaryl-CoA Reductase) (HMGR). Journal of American Science. 4 (3). ISSN 1545 
1003.Availablefrom:URL:http://www.americanscience.org 
 
12. Adam,J.M.F. 2005. Meningkatkan Kolesterol HDL, Paradigma Baru Penatalaksanaan 
Dislipidemi. J.Med Nus, 26(3): 200-204. 
 
13. Fuhrman, B., Elis, A., dan Aviran, M.2002.Hyphocholesterolemic Effect of Lycopene and  
β carotene is Related to Support of Cholesterol Synthesis and Augmentation of LDL 
Receptor Activity in Macrophages. Biochemical and Biophysical Research 
Comunicated. 232(3): 658-662. 
 
14. Maida,H., Tsukui, T., Sashina,T., Hosukawa, M., Miyashita, K. 2008. Seaweed  
Carotenoid, fucoxanthin as a Multifunctional Nutrient. Asia Pac.J Clin 
Nutr.17(S1):196-199 
 
15. Hartoyo, A., dan Astuti,M. 2002. Aktivitas Antioksidatif dan Hipokolesterolemik Ekstrak  
Teh Hijau dan Teh Wangi pada Tikus yang diberi Ransum Kaya Asam Lemak Tidak 
Jenuh Ganda. Jurnal Teknologi dan Industri Pangan. XIII(1) 
 
16. Myers,S. 2005. The Carotenoids Palette. An Array of Colors, Researched Health Benefits 
and Formulation Challengers Highlight the Future of Carotenoids. Available from: 
URL:  http:// www.naturalproductsinsider.com. 23 Juni 2007.  
 
 
 
 
 
 
 
 
 
 
